Aimmune Therapeutics Inc (AIMT)

15.68 +0.27  +1.75% NASDAQ Jul 10, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/07/2020 Misc Aimmune Therapeutics Inc Second Quarter Earnings Conference Call in 2020
08/07/2020 Earnings Aimmune Therapeutics Inc Second Quarter Earnings in 2020 Release
05/27/2020 Misc Aimmune Therapeutics Inc Annual General Meeting for 2019
05/11/2020 16:30 EDT Misc Aimmune Therapeutics Inc First Quarter Earnings Conference Call for 2020
05/11/2020 Earnings Aimmune Therapeutics Inc First Quarter Earnings Result for 2020
02/27/2020 16:30 EST Misc Aimmune Therapeutics Inc Fourth Quarter Earnings Conference Call for 2019
02/27/2020 Earnings Aimmune Therapeutics Inc Fourth Quarter Earnings in 2019 Release
02/27/2020 Misc Aimmune Therapeutics Inc Annual Report for 2019
11/06/2019 16:30 EST Misc Aimmune Therapeutics Inc Third Quarter Earnings Conference Call for 2019
11/06/2019 Earnings Aimmune Therapeutics Inc Third Quarter Earnings for 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.aimmune.com
  • Investor Relations URL: http://ir.aimmune.com/phoenix.zhtml?c=254097&p=irol-irhome
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Aug. 07, 2020
  • Last Earnings Release: May. 11, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Aimmune Therapeutics Inc is a company operating in the United States biotechnology industry. Its main focus is in the development of product candidates to combat peanut and other food allergies. The company's therapeutic approach, which is referred to as Characterized Oral Desensitization Immunotherapy, is a system designed to desensitize patients to food allergens using characterized biologic products, defined treatment protocols, and support services.

Top Fund Holders

Symbol Name Weighting
ETCHX Eventide Healthcare & Life Sciences C 2.75%
F0000155EU ST Healthcare Innovations 9 F CA 2.73%
F000011FZR ST Healthcare Innovations 6 CA 1.72%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.